查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830680

2025年3D生物列印人体组织全球市场报告

3D Bioprinted Human Tissue Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，3D生物列印人体组织的市场规模迅速扩张，从2024年的17亿美元成长到2025年的19.3亿美元，复合年增长率为13.7%。预测期内的成长主要源自于器官移植需求的不断增长、慢性病盛行率的上升、再生医学投资的不断增长、干细胞研究的不断拓展以及个人化医疗的日益普及。

预计未来几年，3D生物列印人体组织市场将快速成长，到2029年将达到31.8亿美元，年复合成长率（CAGR）为13.3%。预测期内的成长动力包括器官移植需求的不断增长、慢性病的流行、再生医学投资的不断增长、干细胞研究的持续扩展以及个性化医疗应用的日益普及。预计这段时期的主要趋势包括生物墨水技术的进步、组织工程的创新、干细胞生物列印的快速发展、研发活动的不断扩展以及多材料、多细胞列印系统的出现。

3D生物列印人体组织是指利用生物列印技术创建的三维结构，该技术涉及逐层沉积活细胞、生物墨水和生物材料来创建组织。 3D生物列印组织的主要目标是为再生医学、药物测试、疾病建模以及未来的器官移植等应用创建功能模型。

3D 生物列印人体组织的主要类型包括皮肤、软骨、肝臟、骨骼和心臟。皮肤组织是指旨在模仿人体保护性外皮的生物列印层，用于创伤治疗和移植应用。使用各种生物列印技术，包括基于挤压的系统、喷墨生物列印、雷射辅助生物列印、微流体、声学方法、磁浮以及混合或 4D 方法。可以使用多种材料，包括天然生物材料、合成生物材料、去细胞细胞外基质、水凝胶和复合材料。这些组织用于组织工程、整容手术、药物测试和开发以及食品测试等领域，并被製药公司、生物技术公司、学术和研究机构、受託研究机构以及医院和诊所等最终用户所使用。

2025年春季美国关税的突然上调及其引发的贸易摩擦正对製药公司造成严重衝击。高利润率的学名药製造商尤其容易受到影响，一些公司正在缩减低收益药品的生产。由于关税导致的专用试剂短缺，生物技术公司正面临临床试验延迟。为此，该产业正在印度和欧洲扩大原料药的生产，增加库存，并游说获得基本药物的贸易豁免。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供 3D 生物列印人体组织市场统计数据，包括全球市场规模、区域份额、3D 生物列印人体组织市场份额的竞争对手、详细的 3D 生物列印人体组织细分市场、市场趋势和机会，以及您在 3D 生物列印方面取得成功所需的人体组织资料。本 3D 生物列印人体组织市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

器官移植需求的不断增长预计将在未来几年推动3D生物列印人体组织市场的成长。器官移植是一种医疗程序，将器官从捐赠者转移到接受者，以替换受损或功能障碍的器官。随着患者寻求能够缩短等待时间、提高存活率并提供可靠移植方案的救命疗法，对此类程序的需求正在增长。 3D生物列印人体组织提供了一种突破性的替代方案，它能够创建患者特异性的功能性组织，从而降低排斥风险并减少对捐赠器官的依赖。例如，2024年1月，美国卫生与公众服务部器官采购和移植网络报告称，2023年共有46,632例来自活体和死者捐赠的器官移植，比2022年增长8.7%，比2021年增长12.7%。因此，器官移植需求的不断成长正在推动3D生物列印人体组织市场的成长。

3D生物列印人体组织市场的公司正在推动患者来源样本优化等创新，以提高药物研发、疾病研究和再生医学领域组织模型的准确性和个人化。患者来源样本优化是指高效利用有限的患者细胞资源，创建多个高品质、生物相关的3D组织模型，从而获得更准确的研究结果。例如，2025年1月，澳洲生物技术公司Inventia Life Science Pty Ltd.将RASTRUM解决方案引入其产品组合，从而能够快速、可重复且准确地创建复杂的3D人体组织模型。这些模型忠实地模拟了真实的人体组织，可用于药物测试、疾病建模和再生医学。透过先进的按需滴加生物列印技术，该平台实现了标准实验室培养板格式的3D细胞培养的自动化和规模化，从而减少了人工操作并降低了差异性。这项进步支持高通量实验并获得一致且生物相关的结果，加速了药物发现并提高了临床前研究的可预测性。

2022年5月，总部位于瑞典的生命科学和生物融合技术供应商BICO Group AB收购了Allegro 3D Inc.，收购金额未揭露。此次收购旨在透过整合Allegro 3D先进的基于光的微影术技术，扩展BICO的生物列印产品组合，并加速组织工程和再生医学领域创新产品的开发。 Allegro 3D是一家总部位于美国的3D生物列印人体组织製造商。

3D生物列印人体组织市场由提供生物列印组织商业性生产、药物测试和开发以及研发服务等服务的营业单位所获得的收益所构成。市场价值包括服务提供者销售的或包含在其服务产品中的任何相关商品的价值。 3D生物列印人体组织市场还包括生物墨水、植入物组织结构、合成聚合物、天然聚合物、水凝胶和支架材料的销售。此市场的价值是指“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球 3D 生物列印人体组织：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球3D生物列印人体组织市场：成长率分析
  • 全球3D生物列印人体组织市场表现：规模与成长，2019-2024年
  • 全球3D生物列印人体组织市场预测：规模与成长，2024-2029年，2034年
  • 全球 3D 生物列印人体组织：总目标市场 (TAM)

第六章 市场细分

  • 全球3D生物列印人体组织市场（按组织类型、性能和预测），2019-2024年，2024-2029年，2034年
  • 皮肤
  • 软骨
  • 肝
  • 骨
  • 心
  • 其他组织类型
  • 全球3D生物列印人体组织市场（依技术、性能及预测），2019-2024年，2024-2029年，2034年
  • 挤压底座
  • 喷墨生物列印
  • 雷射辅助生物列印
  • 微流体和声学
  • 磁浮
  • 混合或 4D
  • 全球3D生物列印人体组织市场：依材料、性能及预测，2019-2024年、2024-2029年、2034年
  • 天然生医材料
  • 合成生医材料
  • 去细胞细胞外基质
  • 水凝胶
  • 复合材料
  • 其他成分
  • 全球3D生物列印人体组织市场：应用、绩效及预测（2019-2024年、2024-2029年及2034年）
  • 组织工程
  • 整容手术
  • 药物测试与开发
  • 食品检验
  • 全球 3D 生物列印人体组织市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 製药公司
  • 生技公司
  • 学术研究机构
  • 合约研究组织
  • 医院和诊所
  • 全球 3D 生物列印人体组织市场：依皮肤类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 创伤治疗应用
  • 化妆品测试模型
  • 皮肤移植置换
  • 全球 3D 生物列印人体组织市场：按软骨类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 关节修復模型
  • 鼻部重组
  • 耳部重组
  • 全球 3D 生物列印人体组织市场：按肝臟、类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 毒性测试模型
  • 疾病模型
  • 移植调查
  • 全球 3D 生物列印人体组织市场：依骨骼类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 整形外科植入
  • 颅骨修復模型
  • 移植骨替代物
  • 全球 3D 生物列印人体组织市场：按心臟、类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 心臟补片的开发
  • 心臟瓣膜模型
  • 心肌再生
  • 全球 3D 生物列印人体组织市场：依组织类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 肾臟模型
  • 肺组织结构
  • 胰臟组织模型

第七章 区域和国家分析

  • 全球3D生物列印人体组织市场：区域表现与预测（2019-2024年、2024-2029年、2034年）
  • 全球 3D 生物列印人体组织市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 3D生物列印人体组织市场：竞争格局
  • 3D生物列印人体组织市场：公司简介
    • 3D Systems Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Inventia Life Science PTY LTD. Overview, Products and Services, Strategy and Financial Analysis
    • Aspect Biosystems Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Cellink Global AB Overview, Products and Services, Strategy and Financial Analysis
    • Prellis Biologics Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Cyfuse Biomedical KK
  • Poietis SAS
  • Fluidform LLC
  • Tissuelabs
  • Brinter Oy
  • EpiBone Inc.
  • Carcinotech Ltd.
  • VoxCell BioInnovation Inc.
  • Organovo Holdings Inc.
  • Biolife 4D
  • Vivax-bio
  • CollPlant Biotechnologies Ltd.
  • Xolo
  • Copner Biotech
  • TissueTinker

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年3D生物列印人体组织市场：提供新机会的国家
  • 2029年3D生物列印人体组织市场：细分领域带来新机会
  • 2029年3D生物列印人体组织市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r37667

3D bioprinted human tissue refers to three-dimensional structures produced using bioprinting technology, which deposits living cells, bioinks, and biomaterials layer by layer to fabricate tissue. The primary goal of 3D bioprinted tissues is to create functional models for applications such as regenerative medicine, drug testing, disease modeling, and, in the future, organ transplantation.

The primary types of 3D bioprinted human tissue include skin, cartilage, liver, bone, heart, and others. Skin tissue refers to bioprinted layers designed to mimic the body's protective outer covering, with applications in wound healing and grafting. Various bioprinting technologies are used, including extrusion-based systems, inkjet bioprinting, laser-assisted bioprinting, microfluidic and acoustic methods, magnetic levitation, and hybrid or 4D approaches. A wide range of materials can be employed, such as natural biomaterials, synthetic biomaterials, decellularized extracellular matrices, hydrogels, composite materials, and others. These tissues are applied in fields such as tissue engineering, cosmetic surgery, drug testing and development, and food testing, and are utilized by end users including pharmaceutical companies, biotechnology firms, academic and research institutions, contract research organizations, and hospitals and clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The 3D bioprinted human tissue market research report is one of a series of new reports from The Business Research Company that provides 3D bioprinted human tissue market statistics, including 3D bioprinted human tissue industry global market size, regional shares, competitors with a 3D bioprinted human tissue market share, detailed 3D bioprinted human tissue market segments, market trends and opportunities, and any further data you may need to thrive in the 3D bioprinted human tissue industry. This 3D bioprinted human tissue market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 3D bioprinted human tissue market size has grown rapidly in recent years. It will grow from $1.70 billion in 2024 to $1.93 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to the rising demand for organ transplantation, the increasing prevalence of chronic diseases, greater investment in regenerative medicine, the expansion of stem cell research, and the growing adoption of personalized medicine.

The 3D bioprinted human tissue market size is expected to see rapid growth in the next few years. It will grow to $3.18 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to the rising demand for organ transplantation, the increasing prevalence of chronic diseases, greater investment in regenerative medicine, the continued expansion of stem cell research, and the growing use of personalized medicine. Key trends anticipated during this period include advancements in bio-ink technologies, innovations in tissue engineering, rapid progress in stem cell bioprinting, expanding research and development activities, and the emergence of multi-material and multi-cell printing systems.

The rising demand for organ transplants is expected to drive the growth of the 3D bioprinted human tissue market in the coming years. Organ transplantation is a medical procedure in which organs are transferred from a donor to a recipient to replace damaged or failing organs. The growing demand for these procedures stems from patients seeking life-saving treatments that reduce waiting times, improve survival rates, and provide reliable transplant solutions. 3D bioprinted human tissue offers a breakthrough alternative by enabling the creation of patient-specific, functional tissues that lower the risk of rejection and reduce reliance on donor organs. For instance, in January 2024, the Organ Procurement and Transplantation Network, a US-based Department of Health and Human Services entity, reported that organ transplants from living and deceased donors totaled 46,632 in 2023, an 8.7% increase over 2022 and a 12.7% increase over 2021 marking the first time more than 40,000 organ transplants were performed in a single year. Therefore, the increasing demand for organ transplants is fueling growth in the 3D bioprinted human tissue market.

Companies in the 3D bioprinted human tissue market are advancing technological innovations such as patient-derived sample optimization to enhance the accuracy and personalization of tissue models for drug discovery, disease research, and regenerative medicine. Patient-derived sample optimization refers to the efficient use of limited patient cells to generate multiple high-quality, biologically relevant 3D tissue models for more precise research outcomes. For example, in January 2025, Inventia Life Science Pty Ltd., an Australia-based biotechnology firm, introduced the RASTRUM solution within its product suite to enable the rapid, reproducible, and precise creation of complex 3D human tissue models. These models closely mimic real human tissues for use in drug testing, disease modeling, and regenerative medicine. Using advanced drop-on-demand bioprinting technology, the platform automates and scales the production of 3D cell cultures in standard lab plate formats, reducing manual work and variability. This advancement supports high-throughput experiments with consistent and biologically relevant results, accelerating discoveries and improving preclinical research predictability.

In May 2022, BICO Group AB, a Sweden-based provider of life science and bioconvergence technologies, acquired Allegro 3D Inc. for an undisclosed amount. This acquisition was aimed at expanding BICO's bioprinting portfolio by incorporating Allegro 3D's advanced light-based photolithography technology to accelerate the development of innovative products in tissue engineering and regenerative medicine. Allegro 3D Inc. is a US-based manufacturer of 3D bioprinted human tissues.

Major players in the 3d bioprinted human tissue market are 3D Systems Corporation, Inventia Life Science PTY LTD., Aspect Biosystems Ltd., Cellink Global AB, Prellis Biologics Inc., Cyfuse Biomedical K.K., Poietis SAS, Fluidform LLC, Tissuelabs, Brinter Oy, EpiBone Inc., Carcinotech Ltd., VoxCell BioInnovation Inc., Organovo Holdings Inc., Biolife 4D, Vivax-bio, CollPlant Biotechnologies Ltd., Xolo, Copner Biotech, and TissueTinker.

North America was the largest region in the 3D bioprinted human tissue market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in 3D bioprinted human tissue market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the 3D bioprinted human tissue market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The 3D bioprinted human tissue market consists of revenues earned by entities by providing services such as commercial manufacturing of bioprinted tissues, drug testing and development, and research and development services. The market value includes the value of related goods sold by the service provider or included within the service offering. The 3D bioprinted human tissue market also includes sales of bioinks, tissue constructs for transplantation, synthetic and natural polymers, hydrogels, and scaffold materials. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

3D Bioprinted Human Tissue Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on 3d bioprinted human tissue market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for 3d bioprinted human tissue ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The 3d bioprinted human tissue market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Tissue Type: Skin; Cartilage; Liver; Bone; Heart; Other Tissue Types
  • 2) By Technology: Extrusion-Based; Inkjet Bioprinting; Laser-Assisted Bioprinting; Microfluidic And Acoustic; Magnetic Levitation; Hybrid Or 4D
  • 3) By Materials: Natural Biomaterials; Synthetic Biomaterials; Decellularized Extracellular Matrices; Hydrogels; Composite Materials; Other Materials
  • 4) By Application: Tissue Engineering; Cosmetic Surgery; Drug Testing And Development; Food Testing
  • 5) By End-User: Pharmaceutical Companies; Biotechnology Firms; Academic Research Institutions; Contract Research Organizations; Hospitals And Clinics
  • Subsegments:
  • 1) By Skin: Wound Healing Applications; Cosmetic Testing Models; Skin Graft Replacements
  • 2) By Cartilage: Joint Repair Models; Nasal Reconstruction; Ear Reconstruction
  • 3) By Liver: Toxicity Testing Models; Disease Modeling; Transplant Research
  • 4) By Bone: Orthopedic Implants; Cranial Repair Models; Bone Graft Substitutes
  • 5) By Heart: Cardiac Patch Development; Heart Valve Models; Myocardial Regeneration
  • 6) By Other Tissue Types: Kidney Models; Lung Tissue Constructs; Pancreatic Tissue Models
  • Companies Mentioned: 3D Systems Corporation; Inventia Life Science PTY LTD.; Aspect Biosystems Ltd.; Cellink Global AB; Prellis Biologics Inc.; Cyfuse Biomedical K.K.; Poietis SAS; Fluidform LLC; Tissuelabs; Brinter Oy; EpiBone Inc.; Carcinotech Ltd.; VoxCell BioInnovation Inc.; Organovo Holdings Inc.; Biolife 4D; Vivax-bio; CollPlant Biotechnologies Ltd.; Xolo; Copner Biotech; TissueTinker.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. 3D Bioprinted Human Tissue Market Characteristics

3. 3D Bioprinted Human Tissue Market Trends And Strategies

4. 3D Bioprinted Human Tissue Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global 3D Bioprinted Human Tissue Growth Analysis And Strategic Analysis Framework

  • 5.1. Global 3D Bioprinted Human Tissue PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global 3D Bioprinted Human Tissue Market Growth Rate Analysis
  • 5.4. Global 3D Bioprinted Human Tissue Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global 3D Bioprinted Human Tissue Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global 3D Bioprinted Human Tissue Total Addressable Market (TAM)

6. 3D Bioprinted Human Tissue Market Segmentation

  • 6.1. Global 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Skin
  • Cartilage
  • Liver
  • Bone
  • Heart
  • Other Tissue Types
  • 6.2. Global 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Extrusion-Based
  • Inkjet Bioprinting
  • Laser-Assisted Bioprinting
  • Microfluidic And Acoustic
  • Magnetic Levitation
  • Hybrid Or 4D
  • 6.3. Global 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Natural Biomaterials
  • Synthetic Biomaterials
  • Decellularized Extracellular Matrices
  • Hydrogels
  • Composite Materials
  • Other Materials
  • 6.4. Global 3D Bioprinted Human Tissue Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tissue Engineering
  • Cosmetic Surgery
  • Drug Testing And Development
  • Food Testing
  • 6.5. Global 3D Bioprinted Human Tissue Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical Companies
  • Biotechnology Firms
  • Academic Research Institutions
  • Contract Research Organizations
  • Hospitals And Clinics
  • 6.6. Global 3D Bioprinted Human Tissue Market, Sub-Segmentation Of Skin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wound Healing Applications
  • Cosmetic Testing Models
  • Skin Graft Replacements
  • 6.7. Global 3D Bioprinted Human Tissue Market, Sub-Segmentation Of Cartilage, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Joint Repair Models
  • Nasal Reconstruction
  • Ear Reconstruction
  • 6.8. Global 3D Bioprinted Human Tissue Market, Sub-Segmentation Of Liver, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Toxicity Testing Models
  • Disease Modeling
  • Transplant Research
  • 6.9. Global 3D Bioprinted Human Tissue Market, Sub-Segmentation Of Bone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Orthopedic Implants
  • Cranial Repair Models
  • Bone Graft Substitutes
  • 6.10. Global 3D Bioprinted Human Tissue Market, Sub-Segmentation Of Heart, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Patch Development
  • Heart Valve Models
  • Myocardial Regeneration
  • 6.11. Global 3D Bioprinted Human Tissue Market, Sub-Segmentation Of Other Tissues, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kidney Models
  • Lung Tissue Constructs
  • Pancreatic Tissue Models

7. 3D Bioprinted Human Tissue Market Regional And Country Analysis

  • 7.1. Global 3D Bioprinted Human Tissue Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global 3D Bioprinted Human Tissue Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific 3D Bioprinted Human Tissue Market

  • 8.1. Asia-Pacific 3D Bioprinted Human Tissue Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China 3D Bioprinted Human Tissue Market

  • 9.1. China 3D Bioprinted Human Tissue Market Overview
  • 9.2. China 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India 3D Bioprinted Human Tissue Market

  • 10.1. India 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan 3D Bioprinted Human Tissue Market

  • 11.1. Japan 3D Bioprinted Human Tissue Market Overview
  • 11.2. Japan 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia 3D Bioprinted Human Tissue Market

  • 12.1. Australia 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia 3D Bioprinted Human Tissue Market

  • 13.1. Indonesia 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea 3D Bioprinted Human Tissue Market

  • 14.1. South Korea 3D Bioprinted Human Tissue Market Overview
  • 14.2. South Korea 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe 3D Bioprinted Human Tissue Market

  • 15.1. Western Europe 3D Bioprinted Human Tissue Market Overview
  • 15.2. Western Europe 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK 3D Bioprinted Human Tissue Market

  • 16.1. UK 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany 3D Bioprinted Human Tissue Market

  • 17.1. Germany 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France 3D Bioprinted Human Tissue Market

  • 18.1. France 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy 3D Bioprinted Human Tissue Market

  • 19.1. Italy 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain 3D Bioprinted Human Tissue Market

  • 20.1. Spain 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe 3D Bioprinted Human Tissue Market

  • 21.1. Eastern Europe 3D Bioprinted Human Tissue Market Overview
  • 21.2. Eastern Europe 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia 3D Bioprinted Human Tissue Market

  • 22.1. Russia 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America 3D Bioprinted Human Tissue Market

  • 23.1. North America 3D Bioprinted Human Tissue Market Overview
  • 23.2. North America 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA 3D Bioprinted Human Tissue Market

  • 24.1. USA 3D Bioprinted Human Tissue Market Overview
  • 24.2. USA 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada 3D Bioprinted Human Tissue Market

  • 25.1. Canada 3D Bioprinted Human Tissue Market Overview
  • 25.2. Canada 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America 3D Bioprinted Human Tissue Market

  • 26.1. South America 3D Bioprinted Human Tissue Market Overview
  • 26.2. South America 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil 3D Bioprinted Human Tissue Market

  • 27.1. Brazil 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East 3D Bioprinted Human Tissue Market

  • 28.1. Middle East 3D Bioprinted Human Tissue Market Overview
  • 28.2. Middle East 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa 3D Bioprinted Human Tissue Market

  • 29.1. Africa 3D Bioprinted Human Tissue Market Overview
  • 29.2. Africa 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. 3D Bioprinted Human Tissue Market Competitive Landscape And Company Profiles

  • 30.1. 3D Bioprinted Human Tissue Market Competitive Landscape
  • 30.2. 3D Bioprinted Human Tissue Market Company Profiles
    • 30.2.1. 3D Systems Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Inventia Life Science PTY LTD. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Aspect Biosystems Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Cellink Global AB Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Prellis Biologics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. 3D Bioprinted Human Tissue Market Other Major And Innovative Companies

  • 31.1. Cyfuse Biomedical K.K.
  • 31.2. Poietis SAS
  • 31.3. Fluidform LLC
  • 31.4. Tissuelabs
  • 31.5. Brinter Oy
  • 31.6. EpiBone Inc.
  • 31.7. Carcinotech Ltd.
  • 31.8. VoxCell BioInnovation Inc.
  • 31.9. Organovo Holdings Inc.
  • 31.10. Biolife 4D
  • 31.11. Vivax-bio
  • 31.12. CollPlant Biotechnologies Ltd.
  • 31.13. Xolo
  • 31.14. Copner Biotech
  • 31.15. TissueTinker

32. Global 3D Bioprinted Human Tissue Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The 3D Bioprinted Human Tissue Market

34. Recent Developments In The 3D Bioprinted Human Tissue Market

35. 3D Bioprinted Human Tissue Market High Potential Countries, Segments and Strategies

  • 35.1 3D Bioprinted Human Tissue Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 3D Bioprinted Human Tissue Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 3D Bioprinted Human Tissue Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer